ArticleBMC geriatrics2026
Multifactorial analysis of risk factors for frailty and cognitive frailty among hospitalized patients.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFrailty and cognitive frailty are important issues in geriatric medicine that exert substantial socioeconomic burdens on healthcare systems. The aim of this study was to examine the association of frailty and cognitive frailty with risk factors across multiple domains and identify the important risk factors for frailty and cognitive frailty.
methodsThe participants of this cross-sectional study were recruited from the Department of Gerontology at the Fifth Affiliated Hospital of Sun Yat-sen University from August 2023 to April 2024. Frailty, cognitive function, anxiety, depression, sleep quality, nutritional status, and activities of daily living (ADL) were evaluated using the FRAIL scale, the Montreal Cognitive Assessment (MoCA), the Hamilton Anxiety Scale (HAMA), the Hamilton Depression Rating Scale (HAMD), the Pittsburgh Sleep Quality Index (PSQI), the Nutrition Risk Screening (NRS)-2002, and the Barthel Index, respectively. Fazekas score was assessed using the Brain 3 T MRI scanner. Multiple logistic and linear regression analyses were employed to investigate the factors associated with frailty and cognitive frailty.
resultsA total of 764 participants (441 women, 323 men; age: mean ± SD: 66.32 ± 9.82 years) were studied. Frailty score was significantly associated with ADL (β = -0.296, P < 0.001), polypharmacy (β = 0.198, P < 0.001), comorbidities (β = 0.250, P < 0.001), HAMD (β = 0.152, P = 0.007), HAMA (β = 0.149, P = 0.006), and Fazekas scores (β = 0.110, P = 0.008) after controlling confounding factors. Multiple logistic regression showed a strong association of cognitive frailty with polypharmacy (OR = 5.393, 95% CI: 1.359–21.404), Fazekas score (OR = 3.591, 95% CI: 1.525–8.459), HAMD (OR = 1.287, 95% CI: 1.080–1.535), and ADL (OR = 0.931, 95% CI: 0.885–0.979).
conclusionsThese findings suggest that various factors contribute to frailty and cognitive frailty. While causal inference requires further validation, the strong and consistent association we observed has several immediate practical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.